Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_020661.2(AICDA):c.452T>C (p.Phe151Ser) | 57379 | AICDA | Pathogenic | 104894327 | RCV000005435; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8757494 | 8757494 | NM_020661.2:c.452T>C | NP_065712.1:p.Phe151Ser | NC_000012.11:g.8757494A>G | OMIM Allelic Variant:605257.0007 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.441C>A (p.Cys147Ter) | 57379 | AICDA | Pathogenic | 104894323 | RCV000005434; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8757505 | 8757505 | NM_020661.2:c.441C>A | NP_065712.1:p.Cys147Ter | NC_000012.11:g.8757505G>T | OMIM Allelic Variant:605257.0006 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.415A>G (p.Met139Val) | 57379 | AICDA | Pathogenic | 104894322 | RCV000005433; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8757823 | 8757823 | NM_020661.2:c.415A>G | NP_065712.1:p.Met139Val | NC_000012.11:g.8757823T>C | OMIM Allelic Variant:605257.0005 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.374G>A (p.Gly125Glu) | 57379 | AICDA | Likely pathogenic | 193922704 | RCV000029304; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8757864 | 8757864 | NM_020661.2:c.374G>A | NP_065712.1:p.Gly125Glu | NC_000012.11:g.8757864C>T | - | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.317T>C (p.Leu106Pro) | 57379 | AICDA | Pathogenic | 104894321 | RCV000005432; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8757921 | 8757921 | NM_020661.2:c.317T>C | NP_065712.1:p.Leu106Pro | NC_000012.11:g.8757921A>G | OMIM Allelic Variant:605257.0004 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.251G>A (p.Trp84Ter) | 57379 | AICDA | Likely pathogenic | 193922703 | RCV000029303; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8757987 | 8757987 | NM_020661.2:c.251G>A | NP_065712.1:p.Trp84Ter | NC_000012.11:g.8757987C>T | - | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.238T>C (p.Trp80Arg) | 57379 | AICDA | Pathogenic | 104894320 | RCV000005431; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8758000 | 8758000 | NM_020661.2:c.238T>C | NP_065712.1:p.Trp80Arg | NC_000012.11:g.8758000A>G | OMIM Allelic Variant:605257.0003 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.203G>A (p.Trp68Ter) | 57379 | AICDA | Pathogenic | 104894325 | RCV000005430; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8758035 | 8758035 | NM_020661.2:c.203G>A | NP_065712.1:p.Trp68Ter | NC_000012.11:g.8758035C>T | OMIM Allelic Variant:605257.0002 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.176_184delTGCTCTTCC (p.Leu59_Leu62delinsPhe) | 57379 | AICDA | Pathogenic | 387906329 | RCV000005437; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8758054 | 8758062 | NM_020661.2:c.176_184delTGCTCTTCC | NP_065712.1:p.Leu59_Leu62delinsPhe | NC_000012.11:g.8758054_8758062delGGAAGAGCA | OMIM Allelic Variant:605257.0009 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.70C>T (p.Arg24Trp) | 57379 | AICDA | Pathogenic | 104894324 | RCV000005429; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8759547 | 8759547 | NM_020661.2:c.70C>T | NP_065712.1:p.Arg24Trp | NC_000012.11:g.8759547G>A | OMIM Allelic Variant:605257.0001 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |
NM_020661.2(AICDA):c.21_39del19 (p.Arg8Asnfs) | 57379 | AICDA | Pathogenic | 387906328 | RCV000005436; | N | MedGen:C1720956,OMIM:605258,ORPHA:101089 | 12 | 8759578 | 8759596 | NM_020661.2:c.21_39del19 | NP_065712.1:p.Arg8Asnfs | NC_000012.11:g.8759578_8759596del19 | OMIM Allelic Variant:605257.0008 | C1720956 605258 Immunodeficiency with hyper IgM type 2 | | |